Literature DB >> 28784329

Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus.

Mario Cazzola1, Paola Rogliani2, Luigino Calzetta2, Davide Lauro3, Clive Page4, Maria Gabriella Matera5.   

Abstract

Chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus (T2DM) often coexist. The mechanistic links between these two diseases are complex, multifactorial, and not entirely understood, but they can influence the approach to treatment. Understanding whether COPD comes first followed by T2DM or vice versa, or whether the two diseases develop simultaneously due to common underlying mechanisms, is important for the development of novel therapeutic approaches to these two important diseases. In this review, we discuss the potential links between COPD and T2DM and pharmacological approaches that might target these links.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; GLP1-R agonists; ROCK inhibitors; glycaemic control; systemic inflammation; type 2 diabetes mellitus

Mesh:

Year:  2017        PMID: 28784329     DOI: 10.1016/j.tips.2017.07.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  14 in total

Review 1.  Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.

Authors:  Joaquim Gea; Antoni Sancho-Muñoz; Roberto Chalela
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 2.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

3.  [The role of counterinsular hormones in the regulation of glucose homeostasis and the pathogenesis of type 2 diabetes mellitus in COPD].

Authors:  V I Kobylyansky
Journal:  Probl Endokrinol (Mosk)       Date:  2021-02-17

4.  Clinical significance of high-mobility group box-1 (HMGB1) in subjects with type 2 diabetes mellitus (T2DM) combined with chronic obstructive pulmonary disease (COPD).

Authors:  Jiayi Huang; Tingting Zeng; Yongjian Tian; Yang Wu; Jianlin Yu; Zihuan Pei; Liming Tan
Journal:  J Clin Lab Anal       Date:  2019-05-25       Impact factor: 2.352

5.  Small airway remodeling in diabetic and smoking chronic obstructive pulmonary disease patients.

Authors:  Nan Wu; Zhenchao Wu; Jian Sun; Mengdie Yan; Bingbing Wang; Xintong Du; Yi Liu
Journal:  Aging (Albany NY)       Date:  2020-05-05       Impact factor: 5.682

6.  Systemic inflammation in patients of chronic obstructive pulmonary disease with metabolic syndrome.

Authors:  Sufia Naseem; Ummul Baneen
Journal:  J Family Med Prim Care       Date:  2019-10-31

7.  Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case-control study.

Authors:  Kuan-Yuan Chen; Sheng-Ming Wu; Chien-Hua Tseng; Kang-Yun Lee; Yu-Huei Lin; Hung-Yi Liu; Li-Nien Chien
Journal:  BMC Pulm Med       Date:  2021-04-29       Impact factor: 3.317

8.  Diabetes and Mortality From Respiratory Diseases: The Japan Collaborative Cohort Study.

Authors:  Mengying Wang; Isao Muraki; Keyang Liu; Kokoro Shirai; Akiko Tamakoshi; Yonghua Hu; Hiroyasu Iso
Journal:  J Epidemiol       Date:  2019-12-14       Impact factor: 3.211

9.  Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I).

Authors:  Ernesto Maddaloni; Luca D'Onofrio; Francesco Alessandri; Carmen Mignogna; Gaetano Leto; Lucia Coraggio; Sara Sterpetti; Giuseppe Pascarella; Ivano Mezzaroma; Miriam Lichtner; Paolo Pozzilli; Felice Eugenio Agrò; Monica Rocco; Francesco Pugliese; Claudio Maria Mastroianni; Raffaella Buzzetti
Journal:  Diabetes Res Clin Pract       Date:  2020-09-21       Impact factor: 5.602

Review 10.  Dysregulated Cell Signaling in Pulmonary Emphysema.

Authors:  Chih-Ru Lin; Karim Bahmed; Beata Kosmider
Journal:  Front Med (Lausanne)       Date:  2022-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.